According to recent clinical guidelines, the current mainstay treatment of breast cancer involves surgical resection with or without radiotherapy, systemic chemotherapy, endocrine therapy, and/or anti-human epidermal growth factor receptor 2 (HER2) therapy13,14. This evidence concerns the gene ERBB2 and breast carcinoma.